(RTTNews) - Moderna Inc. (MRNA) and Catalent Inc. (CTLT) said that they have expanded their strategic collaboration to dedicate a new high-speed vial filling line for the manufacture of the Moderna ...
As part of this expanded agreement, Catalent will now dedicate to Moderna’s use a new high-speed filling line at the site through June 2023, which can be used to manufacture the COVID-19 vaccine and ...
SAN DIEGO, Aug. 24, 2017 /PRNewswire/ -- Ajinomoto Althea, Inc. ("Althea"), a leading service provider of biopharmaceutical contract development and manufacturing drug programs, announces the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results